Interaction of apo-transferrin with anticancer ruthenium complexes NAMI-A and its reduced form

A Phase I and Pharmacological Study with Imidazolium-<b> <i>trans-</i> </b>DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Dick Pluim et al. · Clinical Cancer Research · 2004 · 823 citations · Full text

Medicine, Oncology, Pharmacology +12

Structural basis for iron piracy by pathogenic Neisseria

Nicholas Noinaj, N. Easley, M. Oke et al. · Nature · 2012 · 267 citations

Life Sciences, Infectious Diseases, Microbiology +10

The Crystal Structure of Iron-free Human Serum Transferrin Provides Insight into Inter-lobe Communication and Receptor Binding

Jeremy Wally, Peter J. Halbrooks, Clemens Vonrhein et al. · Journal of Biological Chemistry · 2006 · 256 citations · Full text

Medicine, Biochemistry, Molecular Biology +15

Structure−Activity Relationships for NAMI-A-type Complexes (HL)[<i>trans</i>-RuCl₄L(<i>S</i>-dmso)ruthenate(III)] (L = Imidazole, Indazole, 1,2,4-Triazole, 4-Amino-1,2,4-triazole, and 1-Methyl-1,2,4-triazole):  Aquation, Redox Properties, Protein Binding, and Antiproliferative Activity

Michael Groessl, Erwin Reisner, Christian G. Hartinger et al. · Journal of Medicinal Chemistry · 2007 · 213 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy

M. Pongratz, Petra Schluga, Michael A. Jakupec et al. · Journal of Analytical Atomic Spectrometry · 2004 · 206 citations

Medicine, Oncology, Pharmacology +13